Glycogen distribution and metabolic alterations in the hypermuscular, myostatin mutant compact mice by Kocsis, Tamás
GLYCOGEN DISTRIBUTION AND METABOLIC ALTERATIONS  




Summary of Ph.D. Thesis 
 
Tamás Kocsis, MD 





 Department of Biochemistry 
Doctoral School of Multidisciplinary Medical Science 
Faculty of Medicine  







1. Publications related to the subject of the dissertation: 
Kocsis T, Baán J, Müller G, Mendler L, Dux L, Keller-Pintér A. Skeletal muscle celullarity 
and glycogen distribution in the hypermuscular Compact mice. Eur J Histochem 58: 2353, 
2014. [IF: 2.042] 
 
Kocsis T, Trencsenyi G, Szabo K, Baan JA, Muller G, Mendler L, Garai I, Reinauer H,   
Deak F, Dux L, Keller-Pinter A. Myostatin propeptide mutation of the hypermuscular 
Compact mice decreases the formation of myostatin and improves insulin sensitivity. Am J 
Physiol Endocrinol Metab 312(3):E150-E160, 2017. [IF: 4.142* (2016)] 
 
2. Other full paper published during the Ph.D fellowship: 
Baán JA, Kocsis T, Keller-Pintér A, Müller G, Zádor E, Dux L, Mendler L. The Compact 
mutation of myostatin causes a glycolytic shift in the phenotype of fast skeletal muscles. J 



















Myostatin (Growth/Differentation Factor 8) 
The TGF- (Transforming Growth Factor-superfamily member myostatin is a 
potent regulator of the skeletal muscle mass. Knocking out of the myostatin gene leads to 
increased muscle mass with hyperplasia and hypertrophy of the muscle fibers. Furthermore, 
naturally occurring myostatin gene mutations, e.g., in humans, mouse, cattle, or sheep were 
described resulting in widespread increase of skeletal muscle mass (“double-muscled” 
phenotype). Myostatin regulates the proliferation and differentiation of myoblasts; moreover, 
it also controls the activation and proliferation of satellite cells, the stem cells of skeletal 
muscle. 
 
Myostatin signaling and the regulation of skeletal muscle mass 
TGF-superfamily members signal through heteromeric receptor complexes composed 
of two homodimers each of type I and type II serine/threonine kinase receptors. The activated 
anaplastic lymphoma kinase type I receptor (ALK4 or ALK5) then propagates the signal by 
phosphorylating Smad2/3 transcriptional factors. The phospho-Smad2/3 molecules forms an 
oligomer with Smad4 that translocates into the nucleus where it interacts with Smad binding 
partners to regulate transcription. Beyond the Smad2/3 mediated signaling, myostatin 
influences the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is the key regulator 
of the anabolic and catabolic responses in skeletal muscle. Myostatin stimulates cyclin D1 
degradation though a PI3K/Akt pathway leading to cell cycle arrest. 
 
The role of myostatin in glucose metabolism 
Myostatin-null mice exhibit increased muscle mass, reduced body fat, and  increased 
insulin sensitivity, which depends on AMP-activated protein kinase. In accordance with 
increased insulin sensitivity, also detected elevated levels of GLUT4 (Glucose transporter 
type 4), pAkt and IRS-1 (Insulin Receptor Substrate-1) in mstn −/− muscles. Transgenic 
expression of myostatin propeptide prevents diet-induced obesity and insulin resistance, and 
the overexpression of follistatin-like 3, an inhibitor of members of the TGF family, or 
inhibition of myostatin by dominant-negative myostatin receptor also improves insulin 
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sensitivity. Myostatin was reported to influence the synthesis and secretion of IGF-1 (Insulin-
like Growth Factor 1) in the liver, thereby regulating the amount of circulating IGF-1. 
 
The Compact mutation and the Compact mice 
The naturally occurring Compact mutation of the myostatin gene arose in a selection 
program on protein amount and hypermuscularity conducted at the Technical University of 
Berlin. Genetic analysis of the Hungarian subpopulation of the hypermuscular Compact mice 
identified a 12-bp deletion, denoted Mstn(Cmpt-dl1Abc), in the propeptide of the 
promyostatin. This non-frameshift mutation leads to the shortening of the propeptide region. 
Both the furin cleavage site and the biologically active growth factor domain of myostatin are 
unaffected by the Compact mutation (Figure 1). Therefore, the loss of myostatin activity 
cannot be explained by disruption of the growth factor bioactive domain; however, the 
mutation can lead to misfolding, or defect in secretion and mistargeting of mature myostatin.  
 
                             
Figure 1. Schematic representation of the non-frameshift Compact mutation in the propeptide 
region of promyostatin. 
 
Additional modifier genes should be present to determine the full expression of the 
Compact phenotype; however, these modifier genes of the special Compact genetic 
background have not yet been identified. Markers on several chromosomes (chromosomes 1, 
3, 5, 7, 11, 16 and X) showed linkage with the putative modifiers, and the strongest 






Although the Compact mutation was identified in 1998, its precise molecular effects 
have not yet been examined. In this study, by using a congenic wild-type mice strain with 
wild-type myostatin and Compact genetic background, we could separately study the effect of 
Compact myostatin mutation and genetic background on morphology, metabolism, and 
signaling.  
We defined the following aims in our study: 
1. To analyse the body composition of the Compact mice. 
2. To characterize the tissue glycogen distribution and skeletal muscle cellularity in Compact  
mice. 
3. To examine the metabolic effects of the Compact mutation. 
4. To identify the molecular consequences of the Compact mutation which can regulate skele- 
tal muscle and liver size, and the metabolism.  
 
MATERIALS AND METHODS 
Animals and sample collection 
We performed the study on male, 3-4 and 10 months old Compact (Compact 
myostatin and Compact genetic background), congenic wild-type (wild-type myostatin and 
Compact genetic background), and BALB/c (wild-type myostatin and wild-type genetic 
background) mice. The Compact mice were crossed with BALB/c to introgress the wild-type 
myostatin gene of BALB/c to Compact mice. The wild-type myostatin allele was followed 
through five generations of repeated backcrossing with the Compact line. Heterozygous 
animals of this line in generation B5 were mated inter se to give homozygous wild-type 
animals with Compact genetic background (denoted as congenic wild-type animals). Animal 
experiments conformed to the National Institutes of Health Guide for the Care and Use of 
Laboratory animals (NIH Pub. No. 85-23, Revised 1996) and were approved by the local 
Ethics Committee at the University of Szeged. The quadriceps femoris (QF), gastrocnemius 
(Gastro), tibialis anterior (TA) muscles, and organs were removed. The tissue samples were 





Determination of glycogen and protein content by spectrophotometry 
Muscle and liver glycogen was measured as glucose residues after acidic hydrolysis by 
a standard enzymatic assay. Briefly, following cryogenic milling the samples were digested at 
100°C. After lysis the samples were cooled to room temperature and neutralized. Thereafter, 
the samples were centrifuged and the supernatants were removed. The concentration of 
glucose was determined from the supernatant by Hexokinase kit (Roche, Mannheim, 
Germany). 
Muscle and liver samples were homogenized containing protease inhibitor cocktail (Sigma-
Aldrich, St. Louis, MO, USA) to extract the total protein amount. The incubation of the 
samples was followed by centrifugation to remove cellular debris. The protein content was 
determined by BCA Protein Assay Reagent (Thermo Scientific, Rockford, IL, USA). 
Spectrophotometry was performed on Fluostar Optima (BMG Labtech, Ortenberg, Germany)  
 
PAS-staining 
Glycogen was detected by performing Periodic Acid Schiff (PAS)-staining 
cryosections of the TA muscle and liver samples. Sections were fixed in formaldehyde in 
ethanol and incubated periodic acid, followed by washing. Then the sections were incubated 
in Schiff’s reagent, followed by incubation in potassium metabisulfite solution. Thereafter, 
washing of the slides tap water and deionized water. Finally, the sections were incubated in 
ethanol and toluol, then were mounted with Entellan. 
 
Immunohistochemistry 
Fiber-type analysis was performed cryosections of the midbelly region of TA muscle. 
The sections were blocked, and then incubated with mouse monoclonal primary antibodies. 
BA-D5, sc-71 and BFF3 primary antibodies were used, specific for Myosin Heavy Chain I 
(MyHCI), MyHCIIA and MyHCIIB. After incubation with the peroxidase-conjugated 
secondary antibody, the immunocomplexes were visualized by 3,3'-diaminobenzidine. We 
could not detect BA-D5 positive (MyHCI) fibers in the TA muscle; therefore, the fibers 




Determination of the total fiber number and glycogen content of the whole cross 
sectional area 
Photos were taken using a Nikon Labophot-2 microscope equipped with Olympus 
DP71 camera. The full cross sectional areas (CSAs) of the muscles were reconstructed from 
the microscopic images by Cell*B software (Olympus DP Soft software, Version 3.2., Soft 
Imaging System GmbH; Munster, Germany). The glycogen content of an individual fiber can 
be predicted by multiplying the average intensity of PAS-staining by the CSA of the fiber. 
Average intensity of PAS-staining (0-1 OD), CSAs of all fibers and fiber numbers were 
determined on  the whole muscle CSA on greyscale converted PAS-stained, panoramic 
images by Digimizer software (Medcalc software, Mariakelke, Belgium). 
 
Determination of the glycogen content of the different fiber types 
The fiber-type specific average intensity of PAS-staining and the CSAs of the different 
fiber types were determined on 2-3 representative microscopic fields of both superficial and 
deep regions of the TA muscle. Both the sc-71 (MyHCIIA) and the BF-F3 (MyHCIIB) 
stained regions were matched with the PAS-stained identical regions on serial sections to 
analyze the glycogen content of the different fiber types. 
 
Western blotting 
The M. gastrocnemius and liver samples were homogenized supplemented with 
protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA), natrium-orthovanadate and 
natrium-fluoride. The samples were separated on SDS-polyacrylamide gel, and  were 
transferred onto Protran nitrocellulose membrane (Amersham, GE Healthcare). After 
incubation in blocking agent the membrane was incubated with primary antibodies, followed 
by incubation with appropriate horseradish peroxidase-conjugated anti-IgG secondary 
antibody. ECL reagent (Advansta, Menlo Park, CA, USA) was used for substrate detection, 
and the membrane was exposed to X-ray film for visualization. 
 
Measurement of tissue alanine aminotransferase activity 
The activity of alanine aminotransferase (ALT) enzyme of the liver samples was 
determined by lactate dehydrogenase coupled kinetic colorimetric assay (Diagnosticum Inc., 
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Budapest, Hungary) in accordance with the manufacturer’s instructions. Spectrophotometry 
was performed with Fluostar Optima (BMG Labtech, Ortenberg, Germany). 
 
Intraperitoneal pyruvate, glucose, and insulin tolerance tests 
For intraperitoneal pyruvate tests 3-4 months old male mice were fasted. Blood 
glucose after intraperitoneal pyruvate injection (2 mg pyruvate / 1 g body weight) was 
measured at 15, 30, 45, 60, 90, and 120 min. For intraperitoneal glucose tolerance test, 3-4 
and 10 months old male mice were fasted. The blood glucose after the intraperitoneal glucose 
injection (2 mg glucose / 1 g body weight)  was determined from distal tail vein at 30, 60, 90, 
and 120 min. For intraperitoneal insulin tolerance test (1.0 U / 1 kg body weight; Humulin R, 
Eli Lilly, B.V Grootslag, Netherlands), animals in same age. After the injection of 
intraperitoneal insulin bolus blood glucose was measured at 15, 30, 45, 60, 90, and 120 min. 
 
Small-animal PET/MRI imaging using 2-deoxy-2-(18F)fluoro-D-glucose 
10 months old male mice were injected 18FDG (2-deoxy-2-(18F)fluoro-D-glucose). 
Whole body PET scans were acquired using the preclinical nanoScan PET/MRI system 
(Mediso Ltd., Hungary). For the determination of the anatomical localization of the organs 
and tissues, T1-weighted MRI scans were performed PET volumes were reconstructed using a 
three-dimensional Ordered Subsets Expectation Maximization (3D-OSEM) algorithm (Tera-
Tomo, Mediso Ltd., Hungary). Reconstructed, reoriented and co-registered images were 
further analyzed with InterView™ FUSION (Mediso Ltd., Hungary) dedicated image analysis 
software. Radiotracer uptake was expressed in terms of standardized uptake values (SUVs). 
Ellipsoidal 3-dimensional Volumes of Interest (VOI) were manually drawn around the edge 
of the tissue or organ activity by visual inspection using InterView™ FUSION multi-modal 
visualization and evaluation software (Mediso Ltd., Hungary). 
 
Statistical analysis 
Statistical evaluations were performed by either one-way ANOVA and Newman-
Keuls post-test or unpaired t-test (GraphPad Software Inc., USA). All data are presented as 





Body composition of the Compact mice 
The body weights of the congenic wild-type mice carrying the wild-type myostatin 
gene in Compact genetic background were higher than BALB/c mice, but they were smaller 
than the Compact animals. The absolute weights of individual hindlimb muscles such as 
tibialis anterior, gastrocnemius, or quadriceps femoris muscles were almost 2-times greater in 
Compacts compared with congenic wild-type animals, and they were bigger in congenic wild-
type animals than in BALB/c mice. The muscle weight/body weight ratios showed the highest 
values in Compacts and the lowest in congenic wild-type mice. 
We found that the absolute weight of heart and kidney of the Compact and congenic 
wild-type mice were comparable and higher than that of BALB/c. The absolute weight of 
abdominal fat increased by ~30 % in 3-4 months old and ~50 % in 10 months old congenic 
wild-type compared with Compacts mice, and it was markedly lower in BALB/c group than 
in Compacts. Liver/body weight ratio of Compacts was smaller than that of congenic wild-
type animals in both ages. Abdominal fat/body weight ratios were comparable in Compact 
and BALB/c animals, and it was almost 2-fold higher in congenic wild-type mice. 
 
Tissue glycogen and protein distribution 
To distinguish the role of Compact mutation and the Compact genetic background in 
the regulation of glycogen stores here we compared the glycogen content of Compact, 
congenic wild-type and BALB/c muscles. We found that total glycogen levels of Compact 
muscles were the highest, the congenic wild-type and BALB/c samples contained comparable 
and smaller amount of glycogen. However, the glycogen concentration was the highest 
BALB/c mice and displayed no differences between Compact and congenic wild-type groups. 
Analyzing the total glycogen amount and glycogen concentration we did not observe 
differences between congenic wild-type and Compact groups; the glycogen content/liver 
weight ratio of BALB/c animals was more than 2.5-fold smaller. The visualization of 
glycogen by PAS-staining verified the results of spectrophotometry, weaker staining was 
observed in BALB/c samples. We determined the total protein amount in the investigated 
muscles and we found that the total protein content of the Compact muscles were the highest 
and the congenic wild-type and BALB/c samples contained smaller amount of protein in 
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accordance to total glycogen levels. Furthermore, we measured the total hepatic protein 
content and we found that it was the highest in Compacts and lowest in the congenic wild-
type group. 
 
Muscle characteristics of the Compact mice 
We tested, whether the higher glycogen amount of the Compact muscle is caused by 
the changes in the glycogen content of the individual muscle fibers. To analyze this, first we 
determined the average intensity of PAS-staining and fiber sizes on the whole CSA of the TA 
muscle. The average intensity of PAS-staining did not show significant change in Compact 
muscle fibers compared to those of the wild type muscle, and no significant difference was 
observed regarding the average CSAs of the fibers either. The average intensity of PAS-
staining multiplied by the value of fiber size is suitable to estimate the average glycogen 
content of the individual fibers. Comparing the average glycogen content of the fibers we 
could not detect any significant changes between the two groups of animal. The fiber number 
increased 1.7-fold in Compact animals. Multiplying the average glycogen content of the 
individual fibers by the increased fiber number we detected a similar, two-fold increase in the 
glycogen content of the whole muscle by PAS-staining as measured by spectrophotometry. 
Taken together, the average glycogen content of the individual fibers did not change; 
therefore, the increased fiber number can explain the elevated glycogen amount of the 
Compact TA muscle.  
 
Glycogen content of the different fiber types 
Regarding the fiber composition of the Compact muscle, we could not detect the slow 
MyHCI isoform in TA muscles in accordance with the literature. The ratio of IIB fibers 
increased 1.6-fold with concomitant decreases of IIX and IIA fibers indicating a glycolytic 
shift. Because the number of IIA fibers in Compact TA was very low, we could not perform 
statistical analysis on this type of fibers. Remarkable differences were observed comparing 
the sizes of the different fiber types on the whole CSA of the muscle. As in wild type animals, 
the CSA of type IIB fibers was 1.44-fold larger than those of type IIX; and IIX fibers were 
1.52-fold larger than the IIA ones. In Compact mice we found a similar result: the CSA of 
type IIB fibers was 1.62-fold bigger than those of IIX fibers. Comparing the two mice lines 
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we did not find any differences between the average size of either IIB or IIX fibers. The 
frequency distributions of both the IIX and IIB fiber sizes showed similar shapes in Compact 
and wild type mice. The histograms of IIX fibers revealed right-skewed distribution in both 
groups of animals. In case of IIB fibers the bellshaped curves were wider in Compact and 
BALB/c animals than those of IIX fibers. 
According to fiber size we found similar results, i.e., the area of IIB fibers was the 
greatest, with no differences between the superficial and deep regions of the TA muscle in 
either mouse line, and no changes were observed regarding the fiber sizes of the two mice 
strains. To compare the effect of the Compact mutation on the fiber-type specific glycogen 
content of the muscle, we measured the average intensity of PAS-staining of the different 
fiber types on serial cryosections stained with antibodies against the different types of MyHC 
isoforms and PAS, respectively. 
The average intensity of PAS-staining showed a similar decreasing tendency in a rank 
order IIA>IIX>IIB on the whole CSA of the muscle: IIB fibers exhibited the weakest OD, as 
in the superficial and deep regions in both mouse lines. The average intensity of PAS-staining 
of the different fiber types did not show significant differences between the Compact and 
BALB/c fibers on the whole muscle CSA, and no significant changes could be observed 
comparing the PAS intensity of the fiber types in the superficial and deep regions either. 
However, the frequency distribution revealed differences despite the similar average values of 
intensity of PAS-staining in Compact and wild type mice: the Compact TA muscle contained 
populations of IIX fibers with higher, and IIB fibers with both higher and lower intensity of 
PAS-staining resulting in a wider distribution in mutant animals.  
Next, the average glycogen content of the different fiber types was compared in both 
strains. The average glycogen content of the IIB fibers was greater than those of IIX fibers, 
whereas the IIA was the lowest in the superficial and deep regions of wild type muscle. 
The results indicated significant difference in the superficial region of BALB/c 
animals. The fiber type specific glycogen content on the whole CSA revealed similar 
tendency; however, without any significant changes. In parallel with the frequency 
distribution of PAS intensity, histograms of the average glycogen content showed that the 
Compact TA muscle contains a population of IIX fibers with higher, and IIB fibers with both 
higher and lower glycogen content. 
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Finally, we compared the total glycogen content of the different fiber types in the TA 
muscle. The glycogen index of IIB fibers was the highest, so that the IIB fibers stored the 
most glycogen in both BALB/c and Compact mice. The glycogen index value of IIX fibers 
was 2.7-fold larger in BALB/c mice compared to Compact animals in line with the higher 
number of IIX fibers present in BALB/c mice. In contrast the glycogen index of IIB fibers 
was 1.5-fold bigger in Compacts in good accordance with the increased proportion of IIB 
fibers in Compact mice. 
 
Glucose tolerance and insulin sensitivity are improved by Compact myostatin mutation 
and reduced by Compact genetic background 
Our results did not show any significant changes in fasting blood glucose levels 
comparing Compact mice with age-matched congenic wild-type and BALB/c animals; 
however, the response to exogenous glucose revealed differences between genotypes. 
Compact and BALB/c mice showed greater glucose tolerance compared with age-matched 
congenic wild-type strain. The area under the curve of blood glucose concentrations during 
the glucose tolerance test was significantly higher in congenic wild-type mice compared to 
age-matched Compact and BALB/c.  
We performed insulin tolerance tests to measure blood glucose changes following 
insulin administration. Insulin treatment reduced blood glucose levels in all groups of mice, 
indicating the insulin responsivity. Congenic wild-type mice showed weaker insulin 
sensitivity compared with Compact and BALB/c groups. The area under the curve value 
during insulin tolerance test was significantly higher in congenic wild-types than in Compact 
and BALB/c mice at both ages. Both glucose tolerance and insulin sensitivity tests showed 
comparable results between age-matched Compacts and BALB/c mice. To test the effect of 
aging on glucose tolerance and insulin sensitivity, the area under the curve values were 
compared. The area under the curve values during insulin tolerance test of young animals 
were not significantly different from middle-aged groups, although they tended to be smaller 






Compact mutation increases 18FDG uptake in skeletal muscle, liver, and adipose tissue              
The 18FDG accumulation of the skeletal muscle was comparable in Compacts and 
BALB/c animals, and moderate uptake was observed in congenic wild-type animals. The 
radiotracer uptake of white adipose tissue showed similar results as skeletal muscle, mild 
uptake was observed in the congenic wild-type mice, and it was higher in Compact and 
BALB/c animals. The liver of Compact mice showed the highest SUVmean (standard uptake 
volume), which was followed by the congenic wild-type and BALB/c groups. 
 
Liver characteristics in Compact mice 
We found that liver mass and liver/body weight ratios are not increased in proportion 
to skeletal muscle mass in Compact mice; therefore, we aimed to assess whether ALT activity 
in proportion to body weight is also reduced similarly to myostatin knock-out animals. Our 
data show that total liver ALT activity/body weight ratio was the lowest in Compacts and was 
the biggest in BALB/c mice. Next we administered glucose precursor pyruvate to measure 
hepatic gluconeogenesis. The intraperitoneal pyruvate tolerance test showed that hepatic 
gluconeogenesis increased in Compact and congenic wild-type animals compared to BALB/c 
animals. 
 
The Compact mutation of myostatin propeptide decreases myostatin formation 
We were able to detect mature myostatin dimer in Compact skeletal muscle. Western 
blot analysis showed that the level of mature myostatin dimer was the lowest in Compact 
muscle and highest in BALB/c mice in accordance with the skeletal muscle weights of the 
animals. The anti-propeptide antibody could recognize the mutant propeptide, and the 
expression level of propeptide was proportional to myostatin level when the genotypes were 
compared; the lowest amount was detected in Compact samples. 
 
Effects of Compact myostatin mutation and genetic background on signaling 
We could detect the mature myostatin; therefore, we investigated myostatin signaling 
in both skeletal muscle and liver.  Despite low levels of myostatin protein in Compact skeletal 
muscle, the level of phospo-Smad2 was the highest when the genotypes were compared, 
suggesting the potential role of other TGF- members in Smad2 activation. Phospho-Smad2 
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levels of the liver samples were the lowest in BALB/c mice and the highest in Compacts. The 
level of phospho-Smad1/5/8 was significantly higher in muscles of Compacts compared to 
congenic wild-type samples. However, we have not found any significant differences in 
phospho-Smad1/5/8 levels of liver samples between the genotypes. Furthermore, no 
differences were observed between either muscular or hepatic Smad4 levels. We determined 
the phosphorylation level of Akt. The phospho-AktSer473/Akt ratio of congenic wild-type liver 
was lower than that of Compact and was comparable with BALB/c values. In contrast, 
phospho-AktSer473/Akt ratios were higher in Compact and congenic wild-type muscles 
compared to BALB/c samples in accordance with myostatin levels. 
AS160 (Akt substrate of 160 kDa), a Rab GTPase-activating protein can regulate the 
translocation of GLUT4 glucose transporter to the plasma membrane of insulin sensitive cells. 
The level of phospho-AS160 was lower in congenic wild-type muscle samples comparing to 
those of Compact or BALB/c mice. The GLUT4 expression showed equal levels in Compact 
and congenic wild-type animals, and the level was lower in BALB/c samples. 
 
CONCLUSIONS 
In the present thesis we investigated the effects of the Compact mutation Mstn(Cmpt-
dl1Abc) on the morphology, metabolism, and signaling (Figure 2).  
The major findings of the thesis are as follows: 
 
1. We have found that both the Compact mutant myostatin and the genetic background 
increases the skeletal muscle size. 
 
2. The increased glycogen and protein content of the Compact muscles may lead to increased 
skeletal musle mass. 
 
3. Although the average glycogen content of the individual fibers kept unchanged in Compact 
muscle, the number of IIB and IIX fibers increased leading to increased glycogen content of 




4. Both the Compact myostatin and the genetic background exhibit systemic, metabolic 
effects. 
 
5. The Compact mutation does not influence the absolute weight of the internal organs (heart, 
kidney, liver, abdominal fat) despite the increased absolute weight of the skeletal muscle. 
 
6. The genetic background increases the absolute weight and glycogen content of the liver; 
furthermore, it increases the glucose uptake and hepatic gluconeogenesis. 
 
7. The Compact myostatin decreases adipositiy, improves insulin sensitivity, enhances the 
glucose uptake of the skeletal muscle and white adipose tissue, whereas the genetic 
background has opposite effects. 
 
8. The Compact mutation does not prevent the formation of myostatin; however, it decreases 
the amount of mature myostatin leading to altered activation of Smad2, Smad1/5/8 and Akt. 
 
9. The increased level of phospho-AS160Thr642 in Compact samples myostatin may lead to 
increased glucose uptake of the skeletal muscle. 
                               
                   
Figure 2. The major conclusions of the thesis. The metabolic effects of the Compact myostatin 
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